Patel A - Search Results

1

Evaluation of conserved and variable influenza antigens for immunization against different isolates of H5N1 viruses.

Patel A, Tran K, Gray M, Li Y, Ao Z, Yao X, Kobasa D, Kobinger GP. Patel A, et al. Vaccine. 2009 May 18;27(23):3083-9. doi: 10.1016/j.vaccine.2009.03.023. Epub 2009 Apr 1. Vaccine. 2009. PMID: 19428922

2

Mucosal delivery of adenovirus-based vaccine protects against Ebola virus infection in mice.

Patel A, Zhang Y, Croyle M, Tran K, Gray M, Strong J, Feldmann H, Wilson JM, Kobinger GP. Patel A, et al. J Infect Dis. 2007 Nov 15;196 Suppl 2:S413-20. doi: 10.1086/520603. J Infect Dis. 2007. PMID: 17940978

3

Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules.

Ao Z, Patel A, Tran K, He X, Fowke K, Coombs K, Kobasa D, Kobinger G, Yao X. Ao Z, et al. Among authors: patel a. Antiviral Res. 2008 Jul;79(1):12-8. doi: 10.1016/j.antiviral.2008.02.001. Epub 2008 Mar 6. Antiviral Res. 2008. PMID: 18359097 Free PMC article.

4

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.

Croyle MA, Patel A, Tran KN, Gray M, Zhang Y, Strong JE, Feldmann H, Kobinger GP. Croyle MA, et al. Among authors: patel a. PLoS One. 2008;3(10):e3548. doi: 10.1371/journal.pone.0003548. Epub 2008 Oct 29. PLoS One. 2008. PMID: 18958172 Free PMC article.

5

Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus.

Kobinger GP, Meunier I, Patel A, Pillet S, Gren J, Stebner S, Leung A, Neufeld JL, Kobasa D, von Messling V. Kobinger GP, et al. Among authors: patel a. J Infect Dis. 2010 Apr 1;201(7):1000-6. doi: 10.1086/651171. J Infect Dis. 2010. PMID: 20170374 Free PMC article.

6

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.

Broderick KE, Shen X, Soderholm J, Lin F, McCoy J, Khan AS, Yan J, Morrow MP, Patel A, Kobinger GP, Kemmerrer S, Weiner DB, Sardesai NY. Broderick KE, et al. Among authors: patel a. Gene Ther. 2011 Mar;18(3):258-65. doi: 10.1038/gt.2010.137. Epub 2010 Oct 21. Gene Ther. 2011. PMID: 20962869

7

A porcine adenovirus with low human seroprevalence is a promising alternative vaccine vector to human adenovirus 5 in an H5N1 virus disease model.

Patel A, Tikoo S, Kobinger G. Patel A, et al. PLoS One. 2010 Dec 16;5(12):e15301. doi: 10.1371/journal.pone.0015301. PLoS One. 2010. PMID: 21179494 Free PMC article.

8

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination.

Fagone P, Shedlock DJ, Bao H, Kawalekar OU, Yan J, Gupta D, Morrow MP, Patel A, Kobinger GP, Muthumani K, Weiner DB. Fagone P, et al. Among authors: patel a. Gene Ther. 2011 Nov;18(11):1070-7. doi: 10.1038/gt.2011.59. Epub 2011 May 5. Gene Ther. 2011. PMID: 21544096 Free PMC article.

9

Replication, pathogenicity, shedding, and transmission of Zaire ebolavirus in pigs.

Kobinger GP, Leung A, Neufeld J, Richardson JS, Falzarano D, Smith G, Tierney K, Patel A, Weingartl HM. Kobinger GP, et al. Among authors: patel a. J Infect Dis. 2011 Jul 15;204(2):200-8. doi: 10.1093/infdis/jir077. Epub 2011 May 12. J Infect Dis. 2011. PMID: 21571728

10

Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.

Patel A, Gray M, Li Y, Kobasa D, Yao X, Kobinger GP. Patel A, et al. Vaccine. 2012 Jan 11;30(3):626-36. doi: 10.1016/j.vaccine.2011.11.017. Epub 2011 Nov 23. Vaccine. 2012. PMID: 22119588

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,891 results

Search Page

Filters